CORT Q4 2017 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$53M+123.8% YoY

Gross Profit

$52M97.8% margin

Operating Income

$22M40.7% margin

Net Income

$98M184.6% margin

EPS (Diluted)

$0.77

QoQ Revenue Growth

+24.6%

Cash Flow

Operating Cash Flow

$25M

Free Cash Flow

$25M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$221M

Total Liabilities

$30M

Stockholders' Equity

$191M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$53M	$24M	+123.8%
Gross Profit	$52M	$23M	+124.2%
Operating Income	$22M	$5M	+333.3%
Net Income	$98M	$5M	+2039.0%